Applied Transplantation Immunology
Head of the Group
Dr. Il-Kang Na
Our group is focusing on the analysis of immune defects, which occur both secondary to cancer and its treatment or are found as primary immunodeficiencies in patients. Furthermore, we are monitoring and optimizing strategies of adoptive T cell therapy in cancer mouse models.